LINK Strengthens Presence in Switzerland with Distribution Agreement
News Sep 04, 2015
LINK has announced the appointment of a new distributor in Switzerland - Chemie Brunschwig AG. This is LINK's first formal partnership in Europe, and an important part of its strategy to strengthen Company representation in important market segments, thus increasing access to LINK's range of innovative reagents for oligo therapeutics and diagnostics.
Chemie Brunschwig AG distributes over one million different chemicals, life science products and lab-ware to laboratories ranging from research and development to production in the Swiss market. Founded in 1948, the company has developed a wide R&D user base across industry, hospitals, private and public health labs, research centres, and universities. Located in Basle, on the border to Germany and France in the Bio Valley, staff are able to communicate with customers in all three regional languages.
Emmanuel Picard, Marketing & Sales Manager for Chemie Brunschwig, commented: "We are delighted to agree this partnership with LINK. It is an exciting opportunity to expand our portfolio of products, whilst playing a key role in driving LINK's growth in the region."
Dr David Ricketts, CEO of LINK, added: "In our home market of Europe, there are certain geographical areas where our customers can benefit from increased local representation due to factors such as language and purchasing regulations. It is essential therefore that we give these customers such a service. We have already developed a successful working relationship with Chemie Brunschwig, driving growth in Switzerland, and formally appointing them as our distributor was the next logical step. They are a company very much aligned to our ethos of quality and service, and we look forward to working with them to take our business forward."
New Software Allows Mobile Monitoring of Breathing ProblemsNews
Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.READ MORE
Agilent Announces Expanded Use of Cancer Diagnostic in the USNews
Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).READ MORE
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018